BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7133228)

  • 1. Ceruloplasmin in Hodgkin's disease.
    Koprivová H; Dienstbier Z; Sámal M; Foltýnová V
    Neoplasma; 1982; 29(3):333-40. PubMed ID: 7133228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of laboratory indicators in Hodgkin's disease: preliminary results.
    Ray GR; Wolf PH; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum ceruloplasmin levels in Hodgkin's disease and malignant lymphomas in correlation with serum copper levels.
    Sirsat AV; Raste AS; Talavdekar RV; Advani SH
    Indian J Cancer; 1979 Jun; 16(2):32-4. PubMed ID: 546729
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
    Margerison AC; Mann JR
    Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between serum values of copper, ceruloplasmin, SMAO, SDAO, in health- subjects, in pregnant women and in some pathological conditions (author's transl)].
    Bombardieri G; Rossi L; Bevilacqua E; Fabiani S; Tettamanti P
    Quad Sclavo Diagn; 1976 Jun; 12(2):131-47. PubMed ID: 828961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of some humoral and cytological indices in active stages of Hodgkin's disease].
    Barbui T; Dini E; Chisesi T; Corà R; Franchi F; Cazzavillan M; Battista R
    Haematologica; 1972; 57(9):488-92. PubMed ID: 4125445
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnostic value of determination of ceruloplasmin activity and haptoglobin level in patients with lymphogranulomatosis].
    Vasygova NF; Lorie IuI
    Vestn Akad Med Nauk SSSR; 1974; (12):20-4. PubMed ID: 4446705
    [No Abstract]   [Full Text] [Related]  

  • 8. Value of an enzymatic assay for the determination of serum ceruloplasmin.
    Macintyre G; Gutfreund KS; Martin WR; Camicioli R; Cox DW
    J Lab Clin Med; 2004 Dec; 144(6):294-301. PubMed ID: 15614251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
    Bien E; Balcerska A
    Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phagocytic activity of peripheral blood leukocytes in patients with Hodgkin's disease.
    Sámal M; Kirschnerová Z; Jirkovský J; Foltýnová V; Dienstbier Z
    Czech Med; 1981; 4(4):224-30. PubMed ID: 7035102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum ceruloplasmin levels in patients of leukaemias, Hodgkin's and non-Hodgkin's lymphomas.
    Aggarwal AK; Sanwalka AB; Vadehra PL; Prabhakar BR
    Indian J Pathol Microbiol; 1984 Oct; 27(4):347-52. PubMed ID: 6534868
    [No Abstract]   [Full Text] [Related]  

  • 12. Nucleoli in lymphocytes of the peripheral blood in Hodgkin's disease: I. Changes in the course of the disease.
    Dientsbier Z; Foltýnová V; Rezný Z; Vĕtrovcová E
    Czech Med; 1978; 1(3):142-52. PubMed ID: 699718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
    Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
    Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood copper and ceruloplasmin levels in hemolymphopathies. I. Malignant lymphoma].
    Tura S; Bernardi L; Baccarani M; Sanguinetti F; Branzi A
    G Clin Med; 1968 Nov; 49(11):1090-104. PubMed ID: 5757473
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum ferritin and other biological parameters as indicators of tumor activity in Hodgkin's disease].
    Hermosa V; Mazo E; Baró J; Castillo E; Cordovilla JJ; Carril J; Zubizarreta A
    Sangre (Barc); 1985; 30(2):154-8. PubMed ID: 2409612
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behavior and prognostic significance of serum ceruloplasmin in relation to the histopathological aspect of Hodgkin's disease].
    Pisi E; Di Feliciantonio R; Figus E; Ferri S
    Minerva Med; 1968 Feb; 59(17):944-52. PubMed ID: 5652623
    [No Abstract]   [Full Text] [Related]  

  • 17. Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias.
    Bien E; Balcerska A; Adamkiewicz-Drozynska E; Rapala M; Krawczyk M; Stepinski J
    Clin Biochem; 2009 Jul; 42(10-11):1144-57. PubMed ID: 19376105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum copper compared to erythrocyte sedimentation rate as indicator of disease activity in Hodgkin's disease.
    Asbjörnsen G
    Scand J Haematol; 1979 Mar; 22(3):193-6. PubMed ID: 451449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood ceruloplasmin levels in acute lymphoblastic leukemia and Hodgkin's disease in childhood].
    Masi M; Vecchi V; Vivarelli F; Paolucci P
    Minerva Pediatr; 1975 Jun; 27(22):1223-8. PubMed ID: 1056499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.